Innovation150 series: As Canada celebrates 150 years we look back on Canadian innovations in transfusion and transplantation medicine over the years. A series of posts feature remarkable Canadian progress - past, present and future. Part 1: Dr. Lawrence Bruce Robertson and blood transfusion in the trenches of World War I Part 2: Wartime Service and Canadian Transfusion Medicine Part 3: Meet Canada's Blood-Typing Pioneers In our first three #innovation150 posts on this blog, we brought readers back in time to the early days of Canadian transfusion medicine born out of wartime need during WW I

In this six-part series, Dr. Jeannie Callum, a hospital-based transfusion specialist, shares her real-life experience witnessing the impact of blood donation on patient lives. She provides some fascinating insight into blood transfusion, past and present, and emphasizes the need for male donors and why some donors may be safer for patients.

A new study by Centre for Innovation scientist Dr. Heyu Ni and his research team at St. Michael's Hospital in Toronto clarifies how maternal antibodies can cause fetal growth restriction and miscarriage, and introduces a new therapeutic target: natural killer cells.

ResearchUnits are lay summaries of published research prepared by our colleagues at Canadian Blood Services' Centre for Innovation. They're simple and purposeful tools that report on project outcomes and research conducted by our investigators. Since 2013, 36 ResearchUnits have been published presenting research summaries on a variety of topics related to clincial research, product and process development, blood safety, transfusion practice, and more. They can be found the Our Research Impact section of blood.ca and are published at the rate of about one per month. The latest ResearchUnit has

This post is based on the introduction to the report written by Dr. Dana Devine, Chief Medical and Scientific Officer, and Judie Leach Bennett, Vice-President, General Counsel and Chief Risk Officer. Evaluating value and impact The Centre for Innovation is the organization’s hub for research, education and discovery. Our multi-disciplinary network of internal and external partners and labs across the country uncover the evidence that improves our effectiveness and influences our practices and policies — for the benefit of Canadian patients, and ultimately, the greater health-care system. Our

This post was written by Canadian Blood Services' postdoctoral fellows, Dr. Syed Qadri from Prof. William Sheffield's laboratory in Hamilton and Dr. Maria Loza from Dr. Sandra Ramirez‘s laboratory in Ottawa. They both crossed the Atlantic for ISBT 2017. In June 2017, more than 2000 transfusion medicine community members, scientists, and health policy makers, from across all continents, converged in the Danish capital Copenhagen to attend the 27th Regional Congress of the International Society of Blood Transfusion. Every year, this event brings international experts together to address the core

Innovation150 series: As Canada celebrates 150 years we look back on Canadian innovations in transfusion medicine over the years. A series of posts over the next few weeks feature remarkable Canadian progress -- past, present and future. #Innovation150.

Innovation150 series: As Canada celebrates 150 years we look back on Canadian innovations in transfusion medicine over the years. A series of posts over the next few weeks feature remarkable Canadian progress -- past, present and future. #Innovation150.

The International Collaboration for Transfusion Medicine Guidelines (ICTMG) recently convened a panel to provide guidance for fetal neonatal alloimmune thrombocytopenia (FNAIT). Findings from a systematic review have been recently published in the journal Blood.

Innovation150 series on the RED blog: As Canada celebrates 150 years we look back on Canadian innovations in transfusion medicine over the years. A series of posts over the next few weeks feature remarkable Canadian progress in transfusion medicine past, present and future. #Innovation150.